Has the licensing of respiratory quinolones for adults and the 7-valent pneumococcal conjugate vaccine (PCV-7) for children had herd effects with respect to antimicrobial non-susceptibility in invasive Streptococcus pneumoniae?

OBJECTIVES The aim of the study was to analyse the evolution of antibiotic non-susceptibility in Spanish invasive Streptococcus pneumoniae after licensure of respiratory-quinolones for adults and 7-valent pneumococcal conjugate vaccine (PCV-7) for immunization of children. METHODS All invasive pneumococci received in the Reference Laboratory (January 2000-August 2007; n = 12 957 isolates) were serotyped, and susceptibility to penicillin/erythromycin/levofloxacin was determined. Antibiotic consumption and PCV-7 doses/year were provided by IMS and the manufacturer, respectively. RESULTS In 2000-07, PCV-7 distribution (doses/1000 inhabitants </=59 months age/year) increased from 0.0 to 411.90, and antibiotic consumption (DDD/1000 inhabitants/day) was maintained for beta-lactams ( approximately 16), decreased for macrolides (from 4.4 to 2.7) and increased for respiratory fluoroquinolones (from 0.3 to 2.7). The increase in PCV-7 distribution correlated with a decrease in PCV-7 serotypes prevalence among invasive isolates in children (r = -0.976; P < 0.001) and adults (r = -0.905; P = 0.002). This decrease in PCV-7 serotypes correlated with a decrease in penicillin non-susceptibility in children (r = 0.929; P < 0.001) and adults (r = 0.905; P = 0.002) and with erythromycin non-susceptibility in children (r = 0.833; P = 0.010). Penicillin/erythromycin non-susceptibility in 2000 was significantly higher in paediatric versus adult isolates (penicillin: 51.4% versus 29.2%; erythromycin: 39.5% versus 20.4%), but similar in 2006-07 (20% to 24%). The increase in respiratory quinolones consumption correlated with the increase in levofloxacin non-susceptibility in adults (r = 0.926; P = 0.008) but not in children, with different non-susceptibility rates in 2007 (1.6% versus 0.0%; P = 0.013). CONCLUSIONS This ecological analysis suggests that PCV-7 vaccination in children had a herd effect in adults, but consumption of respiratory quinolones in adults had no effect on pneumococcal susceptibility to levofloxacin in children. Penicillin/erythromycin non-susceptibility decreased along the studied period among paediatric invasive S. pneumoniae isolates to a level similar to that seen in adults.

[1]  N. Khardori.  Emergence of Invasive Pneumococcal Disease Caused by Nonvaccine Serotypes in the Era of 7-Valent Conjugate Vaccine , 2008 .

[2]  L. McGee.  The coming of age of niche vaccines? Effect of vaccines on resistance profiles in Streptococcus pneumoniae. , 2007, Current opinion in microbiology.

[3]  S. Richter,et al.  Antimicrobial use in Europe and antimicrobial resistance in Streptococcus pneumoniae , 2007, European Journal of Clinical Microbiology & Infectious Diseases.

[4]  J. Castilla,et al.  Effectiveness of the 7-valent pneumococcal conjugate vaccine: a population-based case-control study. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[5]  J. Arístegui,et al.  Reduction in pediatric invasive pneumococcal disease in the Basque Country and Navarre, Spain, after introduction of the heptavalent pneumococcal conjugate vaccine , 2007, European Journal of Clinical Microbiology & Infectious Diseases.

[6]  E. Calbo,et al.  Invasive pneumococcal disease among children in a health district of Barcelona: early impact of pneumococcal conjugate vaccine. , 2006, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[7]  Samir Shah,et al.  Emergence of vaccine-related pneumococcal serotypes as a cause of bacteremia. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[8]  F. Baquero,et al.  Geographical and Ecological Analysis of Resistance, Coresistance, and Coupled Resistance to Antimicrobials in Respiratory Pathogenic Bacteria in Spain , 2005, Antimicrobial Agents and Chemotherapy.

[9]  W. Schaffner,et al.  Reduction in high rates of antibiotic-nonsusceptible invasive pneumococcal disease in tennessee after introduction of the pneumococcal conjugate vaccine. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[10]  E. Lewis,et al.  Postlicensure Surveillance for Pneumococcal Invasive Disease After Use of Heptavalent Pneumococcal Conjugate Vaccine in Northern California Kaiser Permanente , 2004, The Pediatric infectious disease journal.

[11]  I. Jado,et al.  Antimicrobial susceptibility and pneumococcal serotypes. , 2002, The Journal of antimicrobial chemotherapy.

[12]  F. Baquero,et al.  Streptococcus pneumoniae resistance to erythromycin and penicillin in relation to macrolide and beta-lactam consumption in Spain (1979-1997). , 2000, The Journal of antimicrobial chemotherapy.

[13]  Mary Jane Ferraro,et al.  Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically : approved standard , 2000 .

[14]  Pneumococcal vaccines. WHO position paper. , 1999, Releve epidemiologique hebdomadaire.

[15]  I. Jado,et al.  Dot blot assay for the serotyping of pneumococci , 1997, Journal of clinical microbiology.

[16]  A. Fenoll,et al.  Serotype distribution and antimicrobial resistance of Streptococcus pneumoniae isolates causing systemic infections in Spain, 1979-1989. , 1991, Reviews of infectious diseases.